Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma
Journal of Visualized Experiments · 2026
DOI: 10.3791/69890 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Shuiling Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Gannan Medical University. Hauptthemen laut MEDLINE: Multiple Myeloma, High-Throughput Nucleotide Sequencing.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Gannan Medical University.
- The First Affiliated Hospital of Gannan Medical University; lcm1430@163.com.
Zitieren
APA
Xie, S., Liao, C., Xin, L., & Lin, C. (2026). Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma. Journal of Visualized Experiments. https://doi.org/10.3791/69890
Vancouver
Xie S, Liao C, Xin L, Lin C. Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma. Journal of Visualized Experiments. 2026. doi:10.3791/69890
BibTeX
@article{Xie2026,
author = {Xie, Shuiling and Liao, Changfeng and Xin, Liuyan and Lin, Chuanming},
title = {Next-Generation Sequencing Clonality Assays: Clinical Validation for Minimal Residual Disease Monitoring in Multiple Myeloma},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/69890}
}
EUVIMED